ADO
Click for more information
0.00% 2.1¢ anteotech ltd

Ellume Clinical Trials, page-13

  1. pac23
    1,787 Posts.
    lightbulb Created with Sketch. 87
    clock Created with Sketch.
    13/09/17
    08:24
    Post #: 27174105
    short memories people - please go back and listen to his interviews and read his reports ->
    all promises & no substance > no $ deals on the table!

    please stop the delusion that Mr Cheshire is going to save this company - history is a fair indicator that it is not a positive move bringing in someone who failed to deliver in the past, imo
    Last edited by pac23: 13/09/17
    ADO Price at posting: 1.7¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
OBM Ora Banda sees FY26 gold output jumping to 150Koz/pa following key approval for Sand King
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $51.83M
Open High Low Value Volume
2.1¢ 2.2¢ 2.1¢ $3.4K 160.9K

Buyers (Bids)

No. Vol. Price($)
4 385314 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 616650 7
View Market Depth
Last trade - 15.20pm 12/07/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.